Navigation Links
SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO

SAN MATEO, CA — April 27, 2007 — SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the following abstracts have been accepted for the Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois on June 1-5, 2007:


ZADAXIN® (thymalfasin, thymosin alpha 1) Poster Presentation
A large first-line, randomized, dose-finding, phase II study on Thymosin alpha 1 (T?1) plus Dacarbazine (DTIC) with or without Interferon alpha (IFN?) vs DTIC plus IFN? in stage IV melanoma. Tumor response and survival results
(ASCO abstract number: 31541)

SCV-07 Abstract Proceedings
Effect of the Immune Modulating Peptide, SCV-07, in the Murine B16 Melanoma Model
(ASCO abstract number: 35151)

For further information about this conference, please visit www.asco.org.

About SciClone
SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development of therapeutics to treat life-threatening diseases. SciClone's lead product ZADAXIN® is currently being evaluated in late-stage clinical trials for the treatment of malignant melanoma and hepatitis C. ZADAXIN is approved for sale in select markets internationally, most notably in China where SciClone has an established sales and marketing operation. A key part of SciClone's strategy is to leverage its advantage in the rapidly growing Chinese market by in-licensing or acquiring the marketing rights to other products, such as DC BeadTM, currently pending Chinese regulatory approval for the treatment of liver cancer. For the U.S. market, SciClone's clinical-stage drug development candidates are SCV-07 for the treatment of viral infectious diseases and RP101 for the treatment of pancreatic cancer. For more information about SciClone, visit www.sciclone.com.






Page: 1 2

Related medicine technology :

1. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SciClone Announces ZADAXIN and SCV Abstracts Accepted ASCO
(Date:7/30/2014)...   Unique Pizza and Subs Corporation ... a Delaware Corporation, is pleased to announce it ... Corporation ("Larasan"), a nature-based pharmaceutical company that produces and ... Larasan will work with Unique to help distribute ... vast distribution network throughout China ...
(Date:7/30/2014)... Germany , July 30, 2014  invendo medical ... computer-assisted ("robotic") colonoscopy system, today announced the appointment of ... device executive, as a new member of its supervisory ... respected global visionary in the medical device industry. In ... Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: GIVN), ...
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... Olympus , a precision technology leader in designing ... Products, among other core businesses, today announced the ... sinus spacing and hemostat products to its already ... foams and powders available in either plant-based or ...
... Services Corp. (RainTree Oncology), a privately-held provider of ... it has signed a distribution agreement with Metro ... of prescription and over-the-counter pharmaceuticals. The agreement marks ... and enables the Company to provide crucial oral ...
Cached Medicine Technology:Olympus Unveils New Dissolvable Post Sinus Surgery Products 2RT Oncology Services Signs Distribution Agreement with Metro Medical Supply, Inc. 2
(Date:7/30/2014)... KY (PRWEB) July 30, 2014 DRE ... pleased to announce the launch of its Medical ... online resource for medical professionals and equipment vendors. , ... shows and conventions in the United States and around ... the calendar, and that number is always growing. , ...
(Date:7/30/2014)... 30, 2014 The Technology Association of ... of TAG (B&TA), today issued its final call for ... , Interested companies have until August 29th 2014 to ... will be selected by the Excalibur Judging Committee. Companies ... with the judges for interviewing process. , The ...
(Date:7/30/2014)... July 30, 2014 LTC Consumer, an independent, ... term care insurance, features an Instant Quote tool on its ... co-founder of LTC Consumer. Quotes are free and unlimited. , ... in only seven areas – including age, gender, and state ... within seconds (you don’t need to enter any contact information ...
(Date:7/30/2014)... 2014 Children’s Hospital of Michigan Foundation ... from 4 p.m. to 7 p.m. Wednesday, August 6 ... Road, Livonia, MI 48152). The event will feature Detroit ... activities, music, snacks and local public safety officials. Kohl’s ... Hospital of Michigan Foundation. , The gift supports ...
(Date:7/30/2014)... at the Monterey Bay Aquarium Research Institute (MBARI) have ... and one half yearslonger than any other known animal. ... and guarded them from predators. This amazing feat represents ... young octopuses of having plenty of time to develop ... for years with little or no food. , Every ...
Breaking Medicine News(10 mins):Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3
... from fungi and lower animals may well be suitable as ... a small protein molecule that can even destroy highly resistant ... and of the Danish company Novozymes AS have shed light ... as a promising lead compound for new antibiotics. These ...
... ... on board a flight from London to Los Angeles helped stabilize a flight attendant who suffered ... Montreal to care for this victim. , ... (Vocus) May 28, 2010 -- Dr. Semira Bayati was onboard United Airlines flight 935 ...
... Helicobacter pylori , which lives in the human stomach and ... a corkscrew, or helix. For years researchers have hypothesized that ... and thrive within the stomach,s acid-drenched environment, but ... first time, researchers at Fred Hutchinson Cancer Research Center have ...
... pleased to announce that Executive Director, Henry Gabelnick, Ph.D, ... International Microbicides 2010 Conference. This year,s conference, Building ... May 22-25 and before an audience of more than ... for his unparalleled commitment and dedication to the development ...
... into place instead of breaking it, researchers explain , ... for the treatment of bunions appears to correct the ... invasive surgery. , The novel procedure -- developed by ... and ankle program and an assistant professor of orthopedic ...
... Study found mood of those with sensitivities worsened when ... -- Allergy season may not mean just the inevitable ... your mood. , Researchers reported that finding at the ... week. , "Depression is a very common disorder and ...
Cached Medicine News:Health News:New weapon against highly resistant microbes within grasp 2Health News:Orange County Plastic Surgeon Helps Stabilize Wounded Flight Attendant Requiring an Emergency Landing 2Health News:Orange County Plastic Surgeon Helps Stabilize Wounded Flight Attendant Requiring an Emergency Landing 3Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 2Health News:Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach 3Health News:Henry Gabelnick receives lifetime achievement award 2Health News:New Bunion Procedure Aims to Replace Invasive Foot Surgery 2Health News:Allergies Might Trigger Depression 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: